Literature DB >> 11020

Some complementary data on AH 5158, an inhibitor of both alpha-and beta-adrenoceptors [proceedings].

P Harichaux, L Hary.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 11020      PMCID： PMC1667557     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  2 in total

1.  Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.

Authors:  I Kennedy; G P Levy
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

2.  Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739
  2 in total
  2 in total

Review 1.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

2.  The electrophysiological effects of intravenous labetalol in man.

Authors:  A Harley; H A Coverdale
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.